The FDA has just approved the first artificial intelligence (AI) program to support breast cancer risk prediction from screening mammograms. The AI model behind CLAIRITY BREAST was trained on millions of images and validated across more than 77,000 mammograms from five geographically distinct screening centers – including hospital-based and free-standing facilities – that collectively serve a diverse patient population, with validation anchored in five-year outcome data.
The AI (deep learning) risk score detected 8.6 cancers per 1,000 patients, compared with 4.4 and 3.8 cancers per 1,000 with the other risk models.
This is a great difference. Every cancer detected saves a life.
It’s not clear from the article how it will be commercialized and brought into widespread clinical practice. The Clairity web site says it will be launched soon.
Wendy